Concepedia

Andrew H Park

AH

Statistics

Publications

3

Citations

1K

H-Index

3

Active since

2007

Affiliations

STCube (United States)(Current)

Institute of Biological Chemistry, Academia Sinica

China Medical University

Asia University

The University of Texas MD Anderson Cancer Center

Andrew H Park is an author at STCube (United States) specializing in pd-l1 blockade, immune checkpoint inhibitors, and immunotherapy.

ORCID

Publications per year

2007–2020

3

Publications

3

Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1

Chia‐Wei Li, Seung-Oe Lim, Ezra M. Chung et al. · Cancer Cell · 2018 · 618 citations · Full text

, , +12

ANAC012, a member of the plant‐specific NAC transcription factor family, negatively regulates xylary fiber development in <i>Arabidopsis thaliana</i>

Jae‐Heung Ko, Seung Hwan Yang, Andrew H Park et al. · The Plant Journal · 2007 · 230 citations

, , +17

Targeting Glycosylated PD-1 Induces Potent Antitumor Immunity

Linlin Sun, Chia-Wei Li, Ezra M. Chung et al. · Cancer Research · 2020 · 173 citations · Full text

, , +17

1–3 of 3